ReviewBlood2019
Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy.
Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it